Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Oxbryta (Voxelotor) Medicine in India

Buy Oxbryta (Voxelotor) Medicine in India

Oxbryta (Voxelotor)

Medicine name : Oxbryta

Generic name : Voxelotor

Manufactured By : Global Blood Theraupeutics

Indications : Sickle cell disease

Medicine Description : Oxbryta is a hemoglobin polymerization inhibitor for sickle cell disease (SCD). It prevents red blood cell damage, reducing anemia and complications. Taken orally, it improves oxygen delivery in the blood. Side effects include headache, diarrhea, fatigue, and liver enzyme elevation. Liver function and hemoglobin monitoring are essential.

Product Introduction

Oxbryta (Voxelotor) is a medicine that was used to treat sickle cell disease by increasing the ability of hemoglobin to hold oxygen and reducing the tendency of red blood cells to become sickle-shaped. It was intended to help improve anemia and reduce the destruction of red blood cells associated with sickle cell disease.

Oxbryta (Voxelotor) was taken orally, with or without food, according to the prescribed dose. However, Oxbryta was voluntarily withdrawn from worldwide markets in September 2024 because clinical data indicated a potential increased risk of death and other serious complications. It is therefore no longer routinely available for treatment of sickle cell disease.

Patients who were previously receiving Oxbryta should speak with their healthcare professional about alternative treatment options and should not restart or continue the medicine without medical advice.

Uses Of Oxbryta (Voxelotor)

Treatment of Sickle Cell Disease

Benefits Of Oxbryta

Oxbryta (Voxelotor) was previously used to treat sickle cell disease by increasing hemoglobin's ability to bind oxygen and reducing the sickling of red blood cells. It was intended to improve anemia by reducing the breakdown of red blood cells and increasing hemoglobin levels. However, Oxbryta was withdrawn from the market worldwide in September 2024 because of safety concerns, including an observed increased risk of death and other serious complications. It should not be started or continued without specific medical advice.

Side Effects Of Oxbryta (Voxelotor)

Some side effects of Oxbryta (Voxelotor) may vary from person to person. Some side effects may improve with time, while others may require medical attention. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Oxbryta (Voxelotor)

  • Headache
  • Diarrhea
  • Abdominal pain
  • Nausea
  • Fatigue
  • Rash
  • Fever
  • Vomiting
  • Increased liver enzyme levels
  • Allergic reactions
How To Use Oxbryta

Oxbryta (Voxelotor) was previously taken as an oral medicine, with or without food, according to the dose prescribed by a healthcare professional. The treatment was used under medical supervision, with regular check-ups and blood tests to monitor hemoglobin levels, liver function, and overall health. However, Oxbryta was withdrawn from the market in 2024 because of serious safety concerns and should not be started or restarted without medical advice.

How Oxbryta (Voxelotor) Works

Oxbryta (Voxelotor) was a hemoglobin oxygen-affinity modifier that increased hemoglobin's ability to hold oxygen. By reducing the tendency of hemoglobin S to polymerize, it helped reduce the sickling and destruction of red blood cells. This mechanism was intended to increase hemoglobin levels and improve anemia associated with sickle cell disease.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol if you have previously used Oxbryta (Voxelotor).

PregnancyCONSULT YOUR DOCTOR

Inform your doctor if you are pregnant or planning to become pregnant. Do not use Voxelotor unless specifically advised by a healthcare professional.

BreastfeedingCONSULT YOUR DOCTOR

Consult your doctor before breastfeeding if you have previously received Voxelotor.

DrivingCONSULT YOUR DOCTOR

If you experience headache, fatigue, dizziness, or other symptoms that affect alertness, avoid driving and consult your doctor.

KidneyCAUTION

Inform your doctor about any kidney problems before using or considering treatment with Voxelotor.

LiverCAUTION

Tell your doctor if you have liver problems, as liver function may require monitoring.

Quick Tips
  • Oxbryta (Voxelotor) was withdrawn from worldwide markets in 2024 because of serious safety concerns.
  • Do not start, restart, or continue treatment with Voxelotor without specific advice from a qualified healthcare professional.
  • If you previously used Oxbryta, discuss alternative treatment options and follow-up care with your doctor.
  • Inform your doctor about any medicines, vitamins, herbal products, or dietary supplements you are taking.
  • Seek medical advice promptly if you develop any new or worsening symptoms after previous use of Voxelotor.
  • Read More About - Oxbryta (Voxelotor) from Pharma Five.
Faq

General Question

Oxbryta (Voxelotor) is a prescription medicine used to treat sickle cell disease in adults and children aged 4 years and older. It helps improve hemoglobin levels and reduce the effects of the disease.

Oxbryta works by increasing the oxygen affinity of hemoglobin, which prevents red blood cells from sickling and breaking down too early. This helps improve oxygen delivery throughout the body.

Oxbryta is approved for use in adults and children 4 years and older with sickle cell disease. It is often prescribed for patients with chronic symptoms or complications related to the condition.

Oxbryta is taken orally, once daily, with or without food. It is available in tablet or tablet-for-suspension form, depending on age and patient needs.

Common side effects include headache, diarrhea, abdominal pain, nausea, rash, and tiredness.

In some cases, Oxbryta may cause serious liver issues or allergic reactions. Regular blood tests are needed to monitor liver function and hemoglobin levels. Seek immediate care for symptoms like yellowing of the skin or severe rash.

Oxbryta is generally taken long-term to manage sickle cell disease, as directed by your doctor. Stopping treatment may cause symptoms to return.

It’s best to avoid or limit alcohol while taking Oxbryta, as alcohol can affect liver function and increase side effects.

The safety of Oxbryta during pregnancy is not fully established. Women should consult their doctor and may be advised to use effective birth control during treatment.

Yes, Oxbryta can interact with other drugs, especially those affecting liver enzymes. Inform your healthcare provider about all medications and supplements you are using.

If you miss a dose, take it as soon as you remember. If its close to your next dose, skip the missed one. Do not take two doses at once.

Yes, Oxbryta can be taken with or without food. Taking it with food may help reduce stomach upset in some patients.

Have regular check-ups and blood tests, avoid activities that increase risk of dehydration or extreme exertion, and report any unusual symptoms to your doctor.

Store Oxbryta at room temperature, away from moisture and heat, and keep it out of reach of children.

Oxbryta is available at major pharmacies and specialty drug providers with a valid prescription. Your healthcare provider can help you access it through the proper channels. Pharma Five assists in its procurement.